Serum magnesium and the risk of prediabetes: a population-based cohort study

Diabetologia

Volumn 60, Issue 5, 2017, Pages 843-853

  Kieboom, Brenda C T ^a,b   Ligthart, Symen ^a   Dehghan, Abbas ^a   Kurstjens, Steef ^c   de Baaij, Jeroen H F ^c,d   Franco, Oscar H ^a   Hofman, Albert ^a,e   Zietse, Robert ^a   Stricker, Bruno H ^a,b   Hoorn, Ewout J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Health Care Inspectorate   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Diabetes; Epidemiology; Insulin resistance; Magnesium; Magnesium regulating genes; Mediation; Population based cohort; Prediabetes; Single nucleotide polymorphism

Indexed keywords

CALCIUM; CREATININE; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MAGNESIUM; POTASSIUM; PROTON PUMP INHIBITOR; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CLAUDIN; CLDN19 PROTEIN, HUMAN; CNNM2 PROTEIN, HUMAN; CYCLINE; FXYD2 PROTEIN, HUMAN; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM6 PROTEIN, HUMAN;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC VARIATION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERMAGNESEMIA; HYPERTENSION; HYPOMAGNESEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RISK; SMOKING; AGED; BLOOD; GENETICS; MIDDLE AGED; PHYSIOLOGY; PREDIABETIC STATE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CLAUDINS; COHORT STUDIES; CYCLINS; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNESIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDIABETIC STATE; RISK FACTORS; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRPM CATION CHANNELS;

EID: 85013466630     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-017-4224-4     Document Type: Article

References (41)

1. Ligthart S, van Herpt TT, Leening MJ et al (2015) Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol 4:44–51
2. Yajnik CS, Smith RF, Hockaday TD, Ward NI (1984) Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J (Clin Res Ed) 288:1032–1034
3. Barbagallo M, Dominguez LJ, Galioto A et al (2003) Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Asp Med 24:39–52
4. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R (1993) Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 21:1024–1029
5. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H (2007) Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 167:956–965
6. Song Y, Manson JE, Buring JE, Liu S (2004) Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27:59–65
7. Kim DJ, Xun P, Liu K et al (2010) Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 33:2604–2610
8. Lopez-Ridaura R, Willett WC, Rimm EB et al (2004) Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 27:134–140
9. Hruby A, Meigs JB, O’Donnell CJ, Jacques PF, McKeown NM (2014) Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged Americans. Diabetes Care 37:419–427
10. Rodriguez-Moran M, Simental Mendia LE, Zambrano Galvan G, Guerrero-Romero F (2011) The role of magnesium in type 2 diabetes: a brief based-clinical review. Magnes Res 24:156–162
11. Hopping BN, Erber E, Grandinetti A, Verheus M, Kolonel LN, Maskarinec G (2010) Dietary fiber, magnesium, and glycemic load alter risk of type 2 diabetes in a multiethnic cohort in Hawaii. J Nutr 140:68–74
12. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL (1999) Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 159:2151–2159
13. Everett CJ, King DE (2006) Serum magnesium and the development of diabetes. Nutrition 22:679
14. Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH (2016) Hypomagnesemia in type 2 diabetes: a vicious circle? Diabetes 65:3–13
15. Hofman A, Brusselle GG, Darwish Murad S et al (2015) The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol 30:661–708
16. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
17. Leening MJ, Kavousi M, Heeringa J et al (2012) Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol 27:173–185
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
19. Meyer TE, Verwoert GC, Hwang SJ et al (2010) Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six loci influencing serum magnesium levels. PLoS Genet 6, e1001045
20. Chan KH, Chacko SA, Song Y et al (2015) Genetic variations in magnesium-related ion channels may affect diabetes risk among African American and Hispanic American women. J Nutr 145:418–424
21. Song Y, Hsu YH, Niu T, Manson JE, Buring JE, Liu S (2009) Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women. BMC Med Genet 10:4
22. Li Y, Willer C, Sanna S, Abecasis G (2009) Genotype imputation. Annu Rev Genomics Hum Genet 10:387–406
23. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34:816–834
24. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Available from www.idf.org/webdata/docs/WHO_IDF_definition_diagnosis_of_diabetes.pdf, accessed 2 February 2017
25. Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14:1707–1723
26. Baron RM, Kenny DA (1986) The moderator mediator variable distinction in social psychological-research—conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182
27. Hayes AF (2009) Beyond Baron and Kenny: statistical mediation analysis in the new millennium. Commun Monogr 76:408–420
28. Dempster AP, Laird NM, Rubin DB (1977) Maximum likelihood from incomplete data Via Em Algorithm. J Roy Stat Soc B Met 39:1–38
29. Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M et al (2015) Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am J Kidney Dis 66:775–782
30. Tosiello L (1996) Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 156:1143–1148
31. Imai K, Keele L, Tingley D (2010) A general approach to causal mediation analysis. Psychol Methods 15:309–334
32. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y (2007) Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 20:237–244
33. 2+ in insulin secretion, insulin signal transduction and insulin resistance. Magnes Res 23:5–18
34. Song Y, He K, Levitan EB, Manson JE, Liu S (2006) Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 23:1050–1056
35. Rodriguez-Moran M, Guerrero-Romero F (2003) Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 26:1147–1152
36. Mooren FC, Kruger K, Volker K, Golf SW, Wadepuhl M, Kraus A (2011) Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab 13:281–284
37. Viering DH, de Baaij JH, Walsh SB, Kleta R, Bockenhauer D (2016) Genetic causes of hypomagnesemia, a clinical overview. Pediatr Nephrol. doi:10.1007/s00467-016-3416-3
38. Sahni J, Nelson B, Scharenberg AM (2007) SLC41A2 encodes a plasma-membrane Mg2+ transporter. Biochem J 401:505–513
39. Claverie-Martin F (2015) Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics. Clin Kidney J 8:656–664
40. Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD (2007) Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50:202–211
41. Meij IC, Koenderink JB, van Bokhoven H et al (2000) Dominant isolated renal magnesium loss is caused by misrouting of the Na+, K+-ATPase gamma-subunit. Nat Genet 26:265–266